CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- 8-K Event Results of operations · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market buy Director bought 186,377 shares at an average $9.84 ($1,833,760)
- 4 Open-market buy Director bought 262,027 shares at an average $7.79 ($2,039,901)
- 4 Open-market buy Director bought 173,589 shares at an average $7.55 ($1,310,677)
- 4 Open-market buy 10% owner bought 72,212 shares at $7.38 ($532,925)
- 4 Open-market buy Director bought 72,212 shares at $7.38 ($532,925)
- 4 Open-market buy 10% owner bought 72,212 shares at $7.38 ($532,925)
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 125,743 shares at $7.20 ($905,350)
- 4 Open-market buy 10% owner bought 507,874 shares at an average $6.09 ($3,094,725)
- 4 Open-market buy 10% owner bought 507,874 shares at an average $6.09 ($3,094,725)
- 4 Open-market buy Director bought 507,874 shares at an average $6.09 ($3,094,725)
- 4 Open-market buy Director bought 241,338 shares at an average $6.34 ($1,529,865)
- 4 Open-market buy Director bought 276,179 shares at $5.25 ($1,449,940)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 4 of 13 · 248 filings